CereVasc
CereVasc, Inc. is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. The Company's first product, the eShunt System, is the first minimally invasive, endovascular, cerebrospinal fluid shunt and delivery componentry designed to avoid the need for invasive surgery and extended hospitalization associated with the current surgical treatment of hydrocephalus using ventriculo-peritoneal shunts.
Last updated on
About CereVasc
Estimated Revenue
$0-$1MEmployees
11-50Funding / Mkt. Cap
$114MCategory
Industry
Medical DevicesLocation
City
AuburndaleState
MassachusettsCountry
United StatesCereVasc
Find your buyer within CereVasc